Title:
COMPOUND ACTING AS PROTEASE-ACTIVATED RECEPTOR 4 (PAR4) INHIBITOR FOR TREATING PLATELET AGGREGATION
Document Type and Number:
WIPO Patent Application WO/2019/218956
Kind Code:
A1
Abstract:
The invention falls within the technical field of chemical medicine. Specifically provided are a series of compounds acting as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation, and a medical use thereof.
Inventors:
WU JUNJUN (CN)
LI SHUO (CN)
WEN XIAOMING (CN)
YANG HUA (CN)
WEI GUOPING (CN)
HU YUNJIN (CN)
QIAN SU (CN)
LI SHUO (CN)
WEN XIAOMING (CN)
YANG HUA (CN)
WEI GUOPING (CN)
HU YUNJIN (CN)
QIAN SU (CN)
Application Number:
PCT/CN2019/086557
Publication Date:
November 21, 2019
Filing Date:
May 13, 2019
Export Citation:
Assignee:
SHENZHEN SALUBRIS PHARM CO LTD (CN)
International Classes:
C07D513/04; A61K31/429; A61K31/437; A61K31/4439; A61K31/496; A61K31/5377; A61P7/02; C07D519/00
Foreign References:
| CN104583218A | 2015-04-29 | |||
| CN104540835A | 2015-04-22 |
Download PDF: